search

Active clinical trials for "Pulmonary Disease, Chronic Obstructive"

Results 1131-1140 of 3300

Single Doses GSK159797 On Patient Safety And Lung Function In Patients With Mild To Moderate Asthma...

Pulmonary DiseaseChronic Obstructive

This study was designed to test safety aspects and effects on lung function of a new dry powder version of GSK159797 for asthmatic subjects to inhale. This will allow comparison with previous studies which have only used inhalation of the drug as a vapour.

Completed8 enrollment criteria

Phase 2 Study - Erdosteine in Patients With CB/COPD

Chronic BronchitisChronic Obstructive Pulmonary Disease

This clinical study is designed to explore dose ranging and identify methods to demonstrate the efficacy of Erdosteine in patients with stable Chronic Bronchitis associated with Chronic Obstructive Pulmonary Disease.

Completed2 enrollment criteria

Study Investigating Repeat Doses Of A New Medication (GSK159797) In Asthmatic Patients

Pulmonary DiseaseChronic Obstructive

This study is designed to determine the efficacy and safety of a new long-acting beta-agonist for asthma patients (GSK159797) following dosing for 14 days.

Completed10 enrollment criteria

Effect of ADC4022 Co-Administered With Budesonide on Pulmonary Inflammation in Subjects With Moderate...

Chronic Obstructive Pulmonary Disease

The purpose of this study is to assess the tolerability and efficacy of inhaled theophylline (ADC4022) on markers of pulmonary inflammation (white blood cells) in induced sputum and in bronchial biopsy samples in subjects with moderate to severe Chronic Obstructive Pulmonary Disease (COPD) when co-administered with budesonide and compared to placebo.

Completed18 enrollment criteria

Efficacy and Safety Comparison of Steroid or Placebo in Combination With Salmeterol and Tiotropium...

Pulmonary DiseaseChronic Obstructive

This efficacy and safety study compares four different combinations of blinded inhaled steroid treatments on top of open-label tiotropium and salmeterol in patients with chronic obstructive pulmonary disease (COPD). The primary objective is the effect on lung function parameters.

Completed7 enrollment criteria

Safety and Tolerability QAT370 Compared to Tiotropium in Patients With Chronic Obstructive Pulmonary...

Chronic Obstructive Pulmonary Disease

This study will assess the safety and tolerability of QAT370 compared to tiotropium in patients with COPD.

Completed11 enrollment criteria

Cognitive Behavioral Therapy for Anxiety and Depression in COPD

AnxietyDepression1 more

The purpose of this study was to examine the efficacy of manualized, short-term group cognitive behavioral therapy for COPD patients suffering from clinically significant symptoms of anxiety and/or depression.

Completed7 enrollment criteria

Evaluation of Onset of Effect in Patients With Severe Chronic Obstructive Pulmonary Disease (COPD)...

Chronic Obstructive Pulmonary Disease (COPD)

This study is to assess the effects with two different inhaled respiratory medications with regards to improvement of lung function, symptoms and morning activities.

Completed6 enrollment criteria

Tiotropium and Salmeterol PK Study in COPD Patients

Pulmonary DiseaseChronic Obstructive

The primary objective of this study is to characterize the pharmacokinetics (i.e. systemic exposure to tiotropium and salmeterol) of tiotropium qd + salmeterol qd or bid versus tiotropium qd and salmeterol bid following 4-week treatment periods in patients with chronic obstructive pulmonary disease (COPD).

Completed8 enrollment criteria

Neuromuscular Electrical Stimulation in Chronic Obstructive Pulmonary Disease (COPD)

Chronic Obstructive Pulmonary Disease

The purpose of this study is to elucidate whether combination of usual pulmonary rehabilitation and neuromuscular electrical stimulation of quadriceps may improve exercise capacity in patients affected by chronic obstructive pulmonary disease (COPD).

Completed5 enrollment criteria
1...113114115...330

Need Help? Contact our team!


We'll reach out to this number within 24 hrs